Press Release – BIORCHESTRA

BIORCHESTRA Pens a Pact Worth up to $861M for Central Nervous System(CNS)-Targeted Polymeric Nanoparticle for Intravenous Delivery of Nucleic Acid Therapies

Post author:biorchestra
Post published:March 27, 2023
Post category:Press Release
Post comments:0 Comments

Back to list BIORCHESTRA Pens a Pact Worth up to $861M for Central Nervous System(CNS)-Targeted Polymeric Nanoparticle for Intravenous Delivery of Nucleic Acid Therapies CAMBRIDGE, Mass. and DAEJEON, South Korea, March 27, 2023 /PRNewswire/…

BIORCHESTRA Participating in Two Upcoming Therapeutic RNA-Focused Events

Post author:biorchestra
Post published:March 14, 2023
Post category:Press Release
Post comments:0 Comments

Back to list BIORCHESTRA Participating in Two Upcoming Therapeutic RNA-Focused Events CAMBRIDGE, Mass. and DAEJEON, South Korea, March 8, 2023 /PRNewswire/ -- BIORCHESTRA, a biotherapeutics company focused on the treatment of rare and degenerative diseases within…

BIORCHESTRA receives Citation from the Korean Minister of Trade, Industry, and Energy

Post author:biorchestra
Post published:December 15, 2022
Post category:Press Release
Post comments:0 Comments

Back to list BIORCHESTRA receives Citation from the Korean Minister of Trade, Industry, and Energy A leader in creating jobs through the advancement of RNA-based therapeuticsA contributor to a high…